ES2655027T3 - Análogos de schweinfurthinas - Google Patents

Análogos de schweinfurthinas Download PDF

Info

Publication number
ES2655027T3
ES2655027T3 ES13769473.3T ES13769473T ES2655027T3 ES 2655027 T3 ES2655027 T3 ES 2655027T3 ES 13769473 T ES13769473 T ES 13769473T ES 2655027 T3 ES2655027 T3 ES 2655027T3
Authority
ES
Spain
Prior art keywords
compound
mmol
alkyl
etoac
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13769473.3T
Other languages
English (en)
Spanish (es)
Inventor
John Kodet
David F. Wiemer
Jeffrey D. Neighbors
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation
Original Assignee
University of Iowa Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation filed Critical University of Iowa Research Foundation
Application granted granted Critical
Publication of ES2655027T3 publication Critical patent/ES2655027T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES13769473.3T 2012-03-26 2013-03-25 Análogos de schweinfurthinas Active ES2655027T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615725P 2012-03-26 2012-03-26
US201261615725P 2012-03-26
PCT/US2013/033722 WO2013148584A1 (en) 2012-03-26 2013-03-25 Schweinfurthin analogues

Publications (1)

Publication Number Publication Date
ES2655027T3 true ES2655027T3 (es) 2018-02-16

Family

ID=49261149

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13769473.3T Active ES2655027T3 (es) 2012-03-26 2013-03-25 Análogos de schweinfurthinas

Country Status (8)

Country Link
US (1) US9428493B2 (enExample)
EP (1) EP2831063B1 (enExample)
JP (1) JP2015512404A (enExample)
CN (1) CN104583203B (enExample)
AU (1) AU2013240007B2 (enExample)
CA (1) CA2868508A1 (enExample)
ES (1) ES2655027T3 (enExample)
WO (1) WO2013148584A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019218384B2 (en) * 2018-02-12 2025-09-04 The Penn State Research Foundation Methods and materials for treating cancer
CN108658949B (zh) * 2018-06-29 2021-05-25 云南大学 一种用作抗肿瘤药物的化合物及其生产方法
FR3124946B1 (fr) * 2021-07-06 2024-11-08 Centre Nat Rech Scient Nouveaux composés dérivés des schweinfurthines G, E, F

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US7358377B2 (en) 2004-03-29 2008-04-15 University Of Iowa Research Foundation Schweinfurthin analogues
WO2009158516A1 (en) 2008-06-27 2009-12-30 University Of Iowa Research Foundation Schweinfurthin analogues
WO2010127235A1 (en) * 2009-04-30 2010-11-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Schweinfurthins and uses thereof

Also Published As

Publication number Publication date
CA2868508A1 (en) 2013-10-03
US9428493B2 (en) 2016-08-30
CN104583203A (zh) 2015-04-29
EP2831063A1 (en) 2015-02-04
JP2015512404A (ja) 2015-04-27
EP2831063A4 (en) 2015-07-29
WO2013148584A1 (en) 2013-10-03
US20150045404A1 (en) 2015-02-12
CN104583203B (zh) 2017-06-13
AU2013240007B2 (en) 2017-06-29
EP2831063B1 (en) 2017-10-04
AU2013240007A1 (en) 2014-10-16
HK1206745A1 (en) 2016-01-15

Similar Documents

Publication Publication Date Title
ES2965746T3 (es) Procesos para producir brivaracetam
ES2685621T3 (es) Procesos para preparar intermedios para la fabricación de inhibidores NEP
ES2577303T3 (es) Procedimientos para la preparación de la forma polimórfica I de hidrogenosulfato de clopidogrel
ES2585221T3 (es) Un proceso para la preparación de 6-(7-((1-aminociclopropil)metoxi)-6-metoxiquinolin-4-iloxi)-n-metil-1-naftamida y productos intermedios sintéticos de la misma
ES2681345T3 (es) Método para producir sepiapterina y tetrahidrolactoilpterina
PT787115E (pt) Processos para a preparacao de derivados de 4a,5,9,10,11,12-hexa-hidro-6h-benzofuro¬3a,3,2-ef|¬2|benzazepina
ES2764223T3 (es) Procedimiento de producción de un derivado de espirooxindol
ES2607089T3 (es) Método de producción de un compuesto intermedio para sintetizar un medicamento
ES2847239T3 (es) Procedimientos para la preparación de 4-alcoxi-3-(acil o alquil)oxipicolinamidas
JP2009502906A (ja) エソメプラゾール及びその塩の製造方法
ES2711188T3 (es) Procedimientos de preparación de compuestos de beta-aminosulfona
KR20150006876A (ko) 광학적으로 순수하고 임의로 치환된 2-(1-히드록시-알킬)-크로멘-4-온 유도체의 제조방법 및 약제 제조에 있어서의 그의 용도
AU2007337481B2 (en) Process for production of precursor compound for radioactive halogen-labeled organic compound
ES2716750T3 (es) Procedimiento de producción de un derivado del ácido valérico ópticamente activo
ES2811271T3 (es) Método para la producción de praziquantel y sus precursores
Zheng et al. Synthesis of enantiopure free and N-benzyloxycarbonyl-protected 3-substituted homotaurines from naturally occurring amino acids
ES2546487T3 (es) Procedimiento para la preparación de derivados de ácido aril- y heteroarilacético
US11053255B2 (en) Synthesis of mahanine and related compounds
CN103709101A (zh) 一类renierramycin G的合成中间体及其制备方法
CN104045646B (zh) 三尖杉酯碱d环中间体合成方法
CN104045645B (zh) 三尖杉酯碱c环中间体的合成方法
CN103833717B (zh) 一种奈必洛尔盐酸盐的合成方法
ES2621804T3 (es) Procedimiento de síntesis de 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trieno-7-carbonitrilo y su aplicación a la síntesis de ivabradina y de sus sales de adición de un ácido farmacéuticamente aceptable
ES2257959B1 (es) Procedimiento de preparacion del acido (1r, 2s) -1. 2-epoxipropilfosfonico.
JPWO2009099169A1 (ja) ケージド化合物